SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 181.62 |
| Enterprise Value ($M) | 179.51 |
| Book Value ($M) | 47.27 |
| Book Value / Share | 0.04 |
| Price / Book | 3.84 |
| NCAV ($M) | 4.36 |
| NCAV / Share | 0.00 |
| Price / NCAV | 41.63 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.11 |
| Return on Assets (ROA) | -0.09 |
| Return on Equity (ROE) | -0.14 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.42 |
| Current Ratio | 3.52 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 45.29 |
| Assets | 88.20 |
| Liabilities | 40.93 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| EFTR – eFFECTOR Therapeutics, Inc. | EGRX – Eagle Pharmaceuticals, Inc. |
| ELOX – Eloxx Pharmaceuticals, Inc. | ELVAF – Evolva Holding SA |
| EMMA – Emmaus Life Sciences, Inc. |
Financial data and stock pages provided by
Fintel.io